liver cirrhosis and portal hypertension in cystic fibrosis
Clicks: 237
ID: 149981
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
237 views
28 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #41 of 96 articles by views in Journal of Asian natural products research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Introduction. As the expected survival improves in individuals with the
cystic fibrosis (CF), so they may be faced with a number of medical
complications. Objective. The aim of this study was to analyze the prevalence
of liver cirrhosis in our CF population as well as the clinical and genetic
characteristics of these patients. Methods. All patients older than 2 years
(n=96) were screened for liver disease. Liver cirrhosis was defined by
ultrasonographic findings of distinct heterogeneity of liver parenchyma and
nodular liver surface and/or by liver biopsy findings. Enlarged spleen,
distended portal vein and abnormal portal venous flow indicated portal
hypertension. Clinical and genotype data were analyzed. Results. Sixteen
patients were found to have liver cirrhosis, three of them with portal
hypertension. All patients had pancreatic insufficiency. Nutritional status
expressed as standard deviation score (Z score) for weight, height, and body
mass index was as follows: zW=-0.40±1.24, zH=-0.83±1.02, and BMI=20.1±2.3. CF
patients with liver cirrhosis generally had mild-to-moderate lung disease,
with average FVC and FEV1 values of 97.1±16.5% of predicted and 87.9±23.5% of
predicted, respectively. Genetic analysis showed high frequency of F508del
mutation in the group with cirrhosis (90.6%). Conclusion. The prevalence of
liver cirrhosis in our CF population older than 2 years was 16.6%. Patients
with pancreatic insufficiency and severe CFTR mutations, especially F508del,
were exposed to higher risk of developing liver cirrhosis. Liver cirrhosis
has no significant impact on the pulmonary function and the nutritional
status, until the end-stage liver disease.
| Reference Key |
stojka2013srpskiliver
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Fuštik Stojka |
| Journal | Journal of Asian natural products research |
| Year | 2013 |
| DOI |
10.2298/SARH1312764F
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.